Telemonitoring bei Herzinsuffizienz

Background Noninvasive remote patient management (RPM) in patients with heart failure (HF) has been shown to reduce the days lost due to unplanned cardiovascular hospital admissions and all-cause mortality in the Telemedical Interventional Management in Heart Failure II trial (TIM-HF2). The health economic implications of these findings are the focus of the present analyses from the payer perspective. Methods and results A total of 1538 participants of the TIM-HF2 randomized controlled trial were assigned to the RPM and Usual Care group. Health claims data were available for 1450 patients (n = 715 RPM group, n = 735 Usual Care group), which represents 94.3% of the original TIM-HF2 patient population, were linked to primary data from the study documentation and evaluated in terms of the health care cost, total cost (accounting for intervention costs), costs per day alive and out of hospital (DAOH), and cost per quality-adjusted life year (QALY). The average health care costs per patient year amounted to € 14,412 (95% CI 13,284–15,539) in the RPM group and € 17,537 (95% CI 16,179–18,894) in the UC group. RPM led to cost savings of € 3125 per patient year (p = 0.001). After including the intervention costs, a cost saving of € 1758 per patient year remained (p = 0.048). Conclusion The additional noninvasive telemedical interventional management in patients with HF was cost-effective compared to standard care alone, since such intervention was associated with overall cost savings and superior clinical effectiveness. Graphical abstract

show abstract

Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial

Sydow

Prescher

Koehler

et al. 2021

Clin Res Cardiol

View full text Add to dashboard Cite

show abstract

Digitalisierung in der Diabetologie — Realität, Herausforderung, Vision

et al. 2019

View full text Add to dashboard Cite

Perspektien digitaler Diabetesprävention: wo wollen wir hin?

2018

View full text Add to dashboard Cite

ZUSAMMENFASSUNGEs ist ein steigendes praktisches und wissenschaftliches Interesse an digitalen Gesundheitsanwendungen wie telemedizinischen Ansätzen zur Steigerung des Diabetesselbstmanagements (DSM) bei Diabetes mellitus Typ 2 zu beobachten. Neben der klinischen Wirksamkeit und Kosteneffektivität von Telemedizin sollten jedoch auch Faktoren, die die Akzeptanz von Telemedizinanwendungen beeinflussen, beachtet werden. Wissenschaftliche Studien legen dabei nahe, dass digitale Ansätze zur Verbesserung des Diabetesselbstmanagement auf behavioristischen Theorien basieren sollten. Eine langfristige Implementierung kann durch die Analyse akzeptanzfördernder Faktoren, wie individuellen Charakteristika des Endnutzers und dessen Einstellungen zu Eigenschaften der technischen Lösungen, unterstützt werden. Methodische Herausforderungen bei der Evaluation von telemedizinischen Anwendungen und deren heterogene Evaluationspraxis haben bisher zu einer limitierten Datenbasis geführt. Innovative Studiendesigns und konzertierte Evaluationsansätze können die steigende Verfügbarkeit digitaler Gesundheitsanwendungen durch evidenzbasierte Empfehlungen begleiten.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Telemonitoring bei Herzinsuffizienz

Cited by 6 publications

References 36 publications

Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial

Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial

Digitalisierung in der Diabetologie — Realität, Herausforderung, Vision

Perspektien digitaler Diabetesprävention: wo wollen wir hin?

Contact Info

Product

Resources

About